Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells

被引:208
作者
Song, LX
Coppola, D
Livingston, S
Cress, D
Haura, EB
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Expt Therapeut & Thorac Oncol Program, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA
[3] Univ S Florida, Coll Med, Dept Interdisciplinary Oncol, Tampa, FL USA
[4] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL USA
关键词
Bcl-2; proteins; Mcl-1; lung cancer; apoptosis; epidermal growth factor receptor; chemotherapy;
D O I
10.4161/cbt.4.3.1496
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Overexpression of anti-apoptotic Bcl-2 family members and deregulation of the pathways that regulate pro-apoptotic family members have been observed in non-small cell lung cancers (NSCLC). Previous reports have identified both Bcl-2 and Bcl-x(L) proteins as survival factors in lung cancer cells since reductions in these proteins can induce apoptosis and sensitize lung cancer cells to apoptosis induced by chemotherapy agents.. Myeloid cell leukemia-1 (Mcl-1), another member of the Bcl-2 family, has been found to be a critical survival factor in hematopoietic cells, yet little data exists for a role of Mcl-1 in human lung cancers. We used NSCLC cell lines to explore how Mcl-1 levels affect lung cancer cell survival and studied tumors from patients to determine expression patterns of Mcl-1. NSCLC cells express abundant Mcl-1 protein and depletion of Mcl-1 levels by antisense Mcl-1 oligonucleotides induces apoptosis in A549 and H 1299 lung cancer cells. Reduction in Mcl-1 levels can sensitize lung cancer cells to apoptosis induced by cytotoxic agents as well as by ionizing radiation. Lung cancer cells overexpressing Mcl-1 are less sensitive to apoptosis induced by chemotherapeutic agents, ZD1839 (an inhibitor of EGFR tyrosine kinase) and Bcl-2 or Bcl-x(L) antisense oligonucleotides. We find that epidermal growth factor (EGF) can enhance Mcl-1 protein levels in an ERK-dependent manner. m Signal transduction agents that reduce Mcl-1 levels correlated with their individual ability to induce apoptosis in lung cancer cells. Finally, NSCLC tumors taken directly from patients have elevated levels of Mcl-1 protein compared with normal adjacent lung tissue. Therefore, agents that target Mcl-1 can induce apoptosis and sensitize cells to apoptosis induced by cytotoxic agents. Mcl-1 protein is overexpressed in a subset of human NSCLC and enhanced levels of Mcl-1 may protect lung cancer cells from death induced by a variety of pro-apoptotic stimuli.
引用
收藏
页码:267 / 276
页数:10
相关论文
共 64 条
  • [1] Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: Analysis of 427 cases
    Anton, RC
    Brown, RW
    Younes, M
    Gondo, MM
    Stephenson, MA
    Cagle, PT
    [J]. HUMAN PATHOLOGY, 1997, 28 (09) : 1079 - 1082
  • [2] Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer
    Apolinario, RM
    vanderValk, P
    deJong, JS
    Deville, W
    vanArkOtte, J
    Dingemans, AMC
    vanMourik, JC
    Postmus, PE
    Pinedo, HM
    Giaccone, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2456 - 2466
  • [3] Down-regulation of Mcl-1 by inhibition of the P13-K/Akt pathway is required for cell shrinkage-dependent cell death
    Araki, T
    Hayashi, M
    Watanabe, N
    Kanuka, H
    Yoshino, J
    Miura, M
    Saruta, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (04) : 1275 - 1281
  • [4] Banerjee D, 2001, Curr Opin Investig Drugs, V2, P574
  • [5] Banerjee D, 1999, CURR OPIN MOL THER, V1, P404
  • [6] Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors
    Bianco, R
    Shin, I
    Ritter, CA
    Yakes, FM
    Basso, A
    Rosen, N
    Tsurutani, J
    Dennis, PA
    Mills, GB
    Arteaga, CL
    [J]. ONCOGENE, 2003, 22 (18) : 2812 - 2822
  • [7] Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small cell lung cancer
    Borner, MM
    Brousset, P
    Pfanner-Meyer, B
    Bacchi, M
    Vonlanthen, S
    Hotz, MA
    Altermatt, HJ
    Schlaifer, D
    Reed, JC
    Betticher, DC
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (5-6) : 952 - 958
  • [8] Ciardiello F, 2000, CLIN CANCER RES, V6, P2053
  • [9] Direct repression of the Mcl-1 promoter by E2F1
    Croxton, R
    Ma, YH
    Song, LX
    Haura, EB
    Cress, WD
    [J]. ONCOGENE, 2002, 21 (09) : 1359 - 1369
  • [10] Antisense strategy shows that Mcl-1 rather than Bcl-2 or BCI-xL is an essential survival protein of human myeloma cells
    Derenne, S
    Monia, B
    Dean, NM
    Taylor, JK
    Rapp, MJ
    Harousseau, JL
    Bataille, R
    Amiot, M
    [J]. BLOOD, 2002, 100 (01) : 194 - 199